Anti-Plt For Failed Thromobolysis | Early DAPT?

The JournalFeed podcast for the week of June 22-26, 2026.

These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.

Thursday’s Spoon Feed:

Tirofiban resulted in greater 90-day excellent neurological outcomes vs. placebo in patients with no medium or large vessel occlusion (LVO) who were not improving with with tenecteplase (TNK), NNT = 9.

Friday’s Spoon Feed:

Dual antiplatelet therapy (DAPT) with ticagrelor plus aspirin vs. placebo in patients with stroke treated with thrombolysis resulted in better 90-day excellent neurological outcome, NNT = 15, without a significant increase in symptomatic intracranial hemorrhage (sICH).